2,673
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Hypophysitis after COVID-19 vaccination in a patient with Rathke’s cleft cyst: A case report

ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon show all
Article: 2297455 | Received 12 Oct 2023, Accepted 17 Dec 2023, Published online: 04 Jan 2024

References

  • Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–4. doi:10.1056/NEJMoa2001017.
  • Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052.
  • Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, et al. HCA lung biological network. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016–1035.e19. doi:10.1016/j.cell.2020.04.035.
  • Aydoğan Bİ, Ünlütürk U, Cesur M. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination. Endocrine. 2022 Oct;78(1):42–46. doi:10.1007/s12020-022-03130-8.
  • Şendur SN, Oğuz SH, Ünlütürk U. COVID-19 vaccination and thyroiditis. Best Pract Res Clin Endocrinol Metab. 2023 Jul;37(4):101759. doi:10.1016/j.beem.2023.101759.
  • Taieb A, Sawsen N, Asma BA, Ghada S, Hamza E, Yosra H, Amel M, Molka C, Maha K, Koussay A, et al. A rare case of grave’s disease after SARS-CoV-2 vaccine: is it an adjuvant effect? Eur Rev Med Pharmacol Sci. 2022 Apr;26(7):2627–2630. doi:10.26355/eurrev_202204_28500.
  • Partenope C, Pedranzini Q, Petri A, Rabbone I, Prodam F, Bellone S. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: a case report. Front Endocrinol (Lausanne). 2023;14:1166953. doi:10.3389/fendo.2023.1166953.
  • Matsuo T, Okubo K, Mifune H, Imao T. Bilateral optic neuritis and hypophysitis with diabetes insipidus 1 month after COVID-19 mRNA vaccine: case report and literature review. J Invest Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231186046. doi:10.1177/23247096231186046.
  • Murvelashvili N, Tessnow A. A case of hypophysitis following immunization with the mRNA-1273 SARS-CoV-2 vaccine. J Invest Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211043386. doi:10.1177/23247096211043386.
  • Markovic N, Faizan A, Boradia C, Nambi S. Adrenal crisis secondary to COVID-19 vaccination in a patient with hypopituitarism. AACE Clin Case Rep. 2022;8(4):171–3. doi:10.1016/j.aace.2022.04.004.
  • Taieb A, Mounira EE. Pilot findings on SARS-CoV-2 vaccine-induced pituitary diseases: a mini review from diagnosis to pathophysiology. Vaccines. 2022;10:2004. doi:10.3390/vaccines10122004.
  • Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–949. doi:10.1016/S1473-3099(21)00224-3.
  • Schimmel J, Alba EL, Chen A, Russell M, Srinath R. Letter to the editor: thyroiditis and thyrotoxicosis after the SARS-CoV-2 mRNA vaccine. Thyroid. 2021;31(9):1440. doi:10.1089/thy.2021.0184.
  • Siolos A, Gartzonika K, Tigas S. Thyroiditis following vaccination against COVID-19: report of two cases and review of the literature. Metabol Open. 2021 Dec;12:100136. doi:10.1016/j.metop.2021.100136.
  • Chienwichai K, Sriinkua P, Chang A. Symptomatic hyponatremia after ChAdOx1 nCoV-19 coronavirus disease-19 vaccination. Clin Nephrol. 2022;98(3):162–166. doi:10.5414/CN110906.
  • Lindner G, Ryser B. The syndrome of inappropriate antidiuresis after vaccination against COVID-19: case report. BMC Infect Dis. 2021;21(1):1000. doi:10.1186/s12879-021-06690-8.
  • Morita S, Tsuji T, Kishimoto S, Uraki S, Takeshima K, Iwakura H, Furuta H, Nishi M, Inaba H, Matsuoka T-A, et al. Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report. BMC Endocr Disord. 2022;22(1):185. doi:10.1186/s12902-022-01095-3.
  • Aliberti L, Gagliardi I, Rizzo R, Bortolotti D, Schiuma G, Franceschetti P, Gafà R, Borgatti L, Cavallo MA, Zatelli MC, et al. Pituitary apoplexy and COVID-19 vaccination: a case report and literature review. Front Endocrinol (Lausanne). 2022 Nov 17;13:1035482. doi:10.3389/fendo.2022.1035482.
  • Taieb A, Asma BA, Mounira EE. Evidences that SARS-CoV-2 vaccine-induced apoplexy may not be solely due to ASIA or VITT syndrome’, commentary on pituitary apoplexy and COVID-19 vaccination: a case report and literature review. Front Endocrinol (Lausanne). 2023 Jan 25;14:1111581. doi:10.3389/fendo.2023.1111581.
  • İ̇remli BG, Şendur SN, Ünlütürk U. Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: postvaccination ASIA syndrome. J Clin Endocrinol Metab. 2021;106(9):2600–2605. doi:10.1210/clinem/dgab373.
  • Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y. ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101412. doi:10.1016/j.beem.2020.101412.
  • Liang Z, Zhu H, Wang X, Jing B, Li Z, Xia X, Sun H, Yang Y, Zhang W, Shi L, et al. Adjuvants for coronavirus vaccines. Front Immunol. 2020 Nov 6;11:589833. doi:10.3389/fimmu.2020.589833.
  • Garvey LH, Nasser S. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit? Br J Anaesth. 2021;126(3):e106–e108. doi:10.1016/j.bja.2020.12.020.
  • Mirza SA, Sheikh AAE, Barbera M, Ijaz Z, Javaid MA, Shekhar R, Pal S, Sheikh AB. COVID-19 and the endocrine system: a review of the current information and misinformation. Infect Dis Rep. 2022 Mar 11;14(2):184–97. doi:10.3390/idr14020023.
  • Gorchane A, Ach T, Sahli J, Abdelkrim AB, Mallouli M, Bellazreg F, Hachfi W, Chaieb MC, Ach K. Uncovering the alarming rise of diabetic ketoacidosis during COVID-19 pandemic: a pioneer African study and review of literature. Front Endocrinol (Lausanne). 2023 Jul 26;14:1234256. doi:10.3389/fendo.2023.1234256.
  • Chigr F, Merzouki M, Najimi M. Autonomic brain centers and pathophysiology of COVID-19. ACS Chem Neurosci. 2020 Jun 3;11(11):1520–1522. doi:10.1021/acschemneuro.0c00265.
  • Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun. 2020 Jul;111:102452. doi:10.1016/j.jaut.2020.102452.
  • Montastruc JL. Pharmacovigilance and drug safety: fair prescribing and clinical research. Therapie. 2022 May-Jun;77(3):261–3. doi:10.1016/j.therap.2022.03.001.